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Abstract
To investigate the neuroprotective effects of bovine colostrums (BC), we evaluate the ability of consuming BC after focal brain ischemia/reperfusion
injury rat model to reduce serum cytokine levels and infarct volume, and improve neurological outcome. Sprague-Dawley rats were randomly divided
into 4 groups; one sham operation and three experimental groups. In the experimental groups, MCA occlusion (2 h) and subsequent reperfusion 
(O/R) were induced with regional cerebral blood flow monitoring. One hour after MCAO/R and once daily during the experiment, the experimental 
group received BC while the other groups received 0.9% saline or low fat milk (LFM) orally. Seven days later, serum pro-inflammatory cytokine
(IL-1β, IL-6, and TNF-α) and anti-inflammatory cytokine (IL-10) levels were assessed. Also, the infarct volume was assessed by using a computerized
image analysis system. Behavioral function was also assessed using a modified neurologic severity score and corner turn test during the experiment.
Rats receiving BC after focal brain I/R showed a significant reduction (-26%/-22%) in infarct volume compared to LFM/saline rats, respectively
(P< 0.05). Serum IL-1β, IL-6, and TNF-α levels were decreased significantly in rats receiving BC compared to LFM/saline rats (P<0 . 0 5 ) .  I n  behavioral
tests, daily BC intake showed consistent and significant improvement of neurological deficits for 7 days after MCAO/R. BC ingestion after focal brain
ischemia/reperfusion injury may prevent brain injury by reducing serum pro-inflammatory cytokine levels and brain infarct volume in a rat model.
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Introduction4)
Ischemic stroke resulting from a major cerebral artery 
occlusion, especially the middle cerebral artery (MCA), by a 
thrombus or embolism comprise most stroke cases [1]. These 
strokes are a leading cause of death and severe disability, and 
place a large burden on healthcare and social service resources 
in most countries [2,3]. The most adequate treatment for acute 
stroke in humans is immediate canalization of occluded arteries 
[4]. Reperfusion of the ischemic region may paradoxically 
exacerbate brain damage via reperfusion injury [5,6].
  Ischemia/ 
reperfusion (I/R)-induced brain damage results from NMDA 
(N-methyl  D-aspartate)-induced excitotoxicity and altered 
intracellular Ca
2+ homeostasis [7]. Secondary injury can be result 
from reactive oxygen species (ROS) formation, inflammatory 
cytokine release, and failed energy metabolism [8-10]. Successful 
neuroprotective agents should interfere with inflammatory 
reactions in the ischemic brain tissue. 
Bovine colostrum (BC, the first milk produced after birth) 
contains many biologically active substances with various 
functions, such as immunoglobulins, anti-bacterial peptides, and 
various growth substances [11]. BC is known to be effective in 
improving or preventing lapses in diseases such as short bowel 
syndrome, chemotherapy-induced mucositis, inflammatory bowel 
disease, necrotizing enterocolitis, non-steroidal anti-inflammatory 
drugs (NSAIDs) induced intestinal injury, liver disease, and 
infective diarrhea [12,13]. Recently, in vivo studies have reported 
that BC decreases serum tumor necrosis factor (TNF-α) and 
interleukin (IL-1β) levels following rat lung tissue intestinal 
ischemia/reperfusion injury [14]. This result indicates that BC 
may have anti-cytokine and anti-inflammatory effects. Few in 
vivo studies have examined the neuroprotective effect of BC on 
rat brains affected by I/R. 
This study aimed to evaluate whether BC consumption after 
rat focal brain ischemia/reperfusion injury reduces serum cytokine 
levels and brain infarct volume, and improves neurological 
outcome.
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Materials and Methods
Animals 
The study was conducted in accordance with the Korean 
Academy of Medical Sciences. Animals were generally anesthetized 
and monitored following corresponding standard procedures 
(Laboratory Animal Manual 2000, Korean Academy of Medical 
Sciences, Seoul). All experimental procedures were approved by 
the Kyung Hee University Medical Center Institutional Animal 
Care and Use Committee, Seoul. Thirty seven Sprague-Dawley 
rats weighting 295 ± 8 g (mean ± standard deviation, 9 weeks 
old) were used. Animals were purchased from Samtako Bio 
Korea Co., Ltd. (Gyeonggi-do, Republic of Korea). A 1-week 
acclimation period to an inverse day and night rhythm (7 p.m.-7 
a.m.) was used before animals were used in the experimental 
protocol. Rats were kept at a constant room temperature (24℃) 
and humidity (55-70%), and received standard rat chow and tap 
water ad libitum. 
Experimental groups 
The rats were randomly assigned to four groups: (1) sham 
group (n = 9) received a sham operation, (2) saline group (n =
12) had middle cerebral artery occlusion/reperfusion (MCAO/R) 
operation and received 6 mL/kg saline perorally, (3) low fat milk 
(LFM) group (n = 8) had occlusion/reperfusion (MCAO/R) 
operation and received 12 mL/kg LFM perorally, (4) and BC 
group (n = 8) had occlusion/reperfusion (MCAO/R) operation 
and received 6 mL/kg defatted liquid BC (Percoba liquid, 
Immuno Dynamics, Ltd., Perry, IA, USA) perorally. Saline, 
FLM, and BC were administered once daily, perorally for seven 
days. The rat chow contained 19.5 g/100 g protein, no albumin, 
60.6 g/100 g carbohydrate, 10 g/100 g fat, and 4.08 kcal/100 
g calories. The BC diet had 6.0 g/dL protein, 2.0 g/dL albumin, 
10 g/100 g carbohydrate, < 0.1 g/dL fat, and 64 kcal/dL calories. 
The LFM formulation had 3.0 g/dL protein, no albumin, 5 g/dL 
carbohydrate, 1.0 g/dL fat, and 40 kcal/dL calories, which was 
adjusted to have half the protein and approximately two-thirds 
the calories of BC.
Rats were treated between 10:00 and 12:00 to avoid non-specific 
effects due to the circadian rhythm. Behavioral functions were 
evaluated at 1, 3, and 7 days after operation. Seven days 
following the operation, rats were anesthetized by 5% isoflurane 
inhalation and blood samples were withdrawn by cardiocentesis. 
Rats were then sacrificed by decapitation and brains were 
removed to measure infarct volume.
Regional cerebral blood flow measurement
Each rat was anesthetized with isoflurane (initiated at 5% and 
maintained at 2%) in 30% oxygen and 70% nitrous oxide using 
a vaporizer and face mask. The rat was mounted in the prone 
position on a dual small animal stereotaxic instrument (David 
Kopf Instruments, Los Angeles, CA, USA). After cranial midline 
incision, a 1-mm burr hole was made with microdrill on both 
sides, 2-mm-posterior and 5-mm-lateral to bregma [15], and the 
rat was placed in the supine position. A laser Doppler probe 
was placed on the burr hole under the rat skull, nearly contacting 
the dura mater and avoiding large vessels, and measured the 
parietal cortical perfusion in the MCA territory. The laser 
Doppler probe was connected to BLF21D laser Doppler flowmeter 
(Transonic systems Inc., Ithaca, NY, USA), and values were 
obtained beginning 10 minutes before the ischemic event until 
15 min after reperfusion [16]. The changes in regional cerebral 
blood flow (rCBF) were expressed as percentages of baseline 
values. Signals were digitized for recording, storage and analysis.
Focal cerebral ischemia/reperfusion 
After the laser Doppler probe was placed on the skull, left 
middle cerebral artery occlusion (MCAO) was induced as described 
by Zea Longa et al. (1989) and revised by Lourbopoulos (2008) 
[17,18]. The left common carotid artery (CCA) and external 
carotid artery (ECA) were exposed under an operation 
microscope followed by electrical coagulation of ECA branches. 
The internal carotid artery (ICA) was dissected to the level of 
the pterygopalatine artery. After the distal ECA was ligated 
permanently, a silk thread (6-0) was placed loosely around the 
ECA stump. The CCA and ICA were occluded temporarily using 
microvascular clips. A small incision was made on the ECA, 
and a 25-mm nylon thread (4-0), with a rounded tip and silicon 
rubber cylinder (300-340 ㎛ in diameter) was inserted. The silk 
thread was held around the ECA stump to prevent bleeding, and 
the microvascular clip on the ICA was removed. The nylon thread 
in the ECA was gently advanced through the ICA until Laser 
Doppler Flowmetry showed a sharp decrease in regional blood 
flow in the MCA to approximately 20% of baseline, as 
determined by monitoring [19]. The microvascular clip on the 
CCA was removed and the incision closed. Two hours after 
inducing ischemia, reperfusion was performed by removing the 
nylon thread from the ICA under enflurane anesthesia as 
described above. Restoration of blood flow was identified in the 
operation field and confirmed by laser Doppler flowmetry. 
Animals in the sham operation group were subjected to the same 
operation without inserting the nylon filament. Rectal 
temperature was monitored continuously and maintained at 37.0
±0 . 5 ℃ using an electrical blanket and heating lamp throughout 
the experiment.
Infarct volume measurement
Extracted brains from sacrificed rats were chilled in ice-cold 
saline for 5 min, and sectioned coronally into six 2-mm slices 
using a rat brain matrix (RBM-4000C, ASI® Instruments Inc., 
Warren, MI, USA). The slices were then immersed in saline 198 Neuroprotective effects of bovine colostrums
Table 1. Protein/calorie intake including gavage solution
Group
g/100 g of body weight/4 days
Chow intake Protein intake Calorie intake
Sham 81.49 ± 2.78 16.54 ± 1.18 338.02 ± 10.82
Saline 72.61 ± 2.37* 14.44 ± 1.10 319.59 ± 8.33
LFM 72.68 ± 2.65* 14.95 ± 1.36 319.95 ± 6.51
BC 74.55 ± 2.51 15.05 ± 1.32 321.68 ± 8.05
Values  are  mean ± SE.
* P < 0.05  compared  with  sham  group
Fig. 1. Representative changes in regional cerebral blood flow (rCBF) during 
MCAO/R among saline (SAG), low fat milk (LFMG), and bovine colostrum 
groups (BCG).  The  rCBF  decreased  similarly  in  SAG,  LFMG,  and  BCG  during 
M C A O  a n d  i n c r e a s e d  s i m i l a r l y  i n  a l l  g r o u p s  a f t e r  M C A R  ( P > 0.05,  n = 8  to  12). 
Values  are  mean ± SEM ;  n = 8  to  12.
solution containing 2% 2,3,5-triphenyltetrazolium chloride (TTC; 
Sigma, St. Louis, MO, USA) for 30 min at 37℃ in the dark, 
followed by 10% buffered formalin fixation [16]. Brain slices 
were photographed using a digital camera (Camedia C-5060WZ, 
Olympus Corporation, Tokyo, Japan) and infarct areas were 
quantified using an image analysis system (Optimas 6.5 Media 
Cybermetics, Silver Springs, MD, USA). The infarct area in each 
slice was calculated by subtracting the normal (ipsilateral) area 
from the contralateral hemisphere to reduce errors due to cerebral 
edema, and was presented as a percentage of normal [20].
Cytokine measurement
Serum IL-1β, TNF-α, IL-6, and IL-10 concentrations were 
measured with commercially available quantitative sandwich 
enzyme-linked immunosorbent assay (ELISA) kits (Quantikine 
M, R&D Systems Inc. Minneapolis, MN, USA). The change in 
absorbance in each well at 450 nm was measured with a 
microplate reader (model ELx800; Bio-Tek Instruments Inc., 
Winooski, VT, USA) and levels were expressed as picograms 
per milliliter. 
Behavioral function assessment 
Tests were performed by a blinded investigator at predetermined 
times to exclude behavioral changes associated with the circadian 
rhythm.
The modified neurologic severity scores (mNSS) is a composite 
of motor, sensory (visual, tactile and proprioceptive), and reflex 
tests. Neurological function was graded on a scale of 0-18 
(normal score 0; maximal deficit score 18). One point is awarded 
for the inability to perform a test or the lack of a tested reflex; 
thus, a higher score denotes a more severe injury [21].
In the corner test, a rat was placed between two 30 cm×20 
cm×1 cm boards. The edges of the boards were attached at a 
30° angle with a small opening between the boards to encourage 
entry into the corner. The rat was placed between the two angled 
boards facing the corner and halfway to the corner. When the 
rat reached the corner, both sides of the body were simultaneously 
stimulated. Then the animal usually reared and turned either right 
or left. Each animal was tested in 10 trials, and the chosen sides 
for turning were noted. In the case of ventral turning (i.e., when 
the animal turned without rearing), the trial was discarded and 
repeated at the end of the session. The laterality index was 
calculated according to the formula: Laterality index = (number 
of left turns-number of right turns) / total number of turns [22].
Statistical analysis
All data were given as mean ± SE values. Differences between 
groups were evaluated by analysis of variance (ANOVA) 
followed by Student-Newman-Keuls multiple comparison test. 
Statistical analyses were performed with SPSS for Windows 13.0 
software (SPSS Inc., Chicago, IL). Differences between two 
groups were compared by Student’s t-test. A P value < 0.05 was 
considered statistically significant.
Results
Food intake and general conditions 
Average body weights were increased to approximately 
285-330 g during the experimental period. Rat chow intake was 
decreased significantly in saline and LFM groups compared to 
the sham group (P< 0.05), but there was no significant difference 
between sham and BC groups. Protein and calorie intakes were 
similar among all groups (Table 1).
Regional cerebral blood flow measurement
The regional cerebral blood flow (rCBF) was decreased during 
MCAO and showed the same basic patterns in all three operation 
groups. The rCBF reduction during MCAO tended to be slightly 
less severe in the LFM group compared with the saline or BC 
groups (LFM, 24.5 ± 4.5% of baseline; Saline, 20.5 ± 2.5% of 
baseline; BC, 20.3 ± 2.6% of baseline), but there were no 
significant differences among the MCAO/R groups (P >0 . 0 5 ) .  
rCBF was also increased following the same basic pattern for Han Sung Choi et al. 199
(A)
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Fig. 2. Effects of treatment with saline, LFM, and BC on brain infarct volume 
in rats. (A) Representative photographs of TTC staining 7 days after MCAO/R. Infarct 
v o l u m e  i n  s h a m  o p e r a t i o n  ( S H G ) ,  s a l i n e  ( S A G ) ,  l o w  f a t  m i l k  ( L F M G),  and  bovine 
colostrum groups (BCG). (B) Brain infarct volume in BCG was smaller than SAG 
and LFMG. Values are mean ± SEM ; n = 8 to 12 (* P < 0.001 vs SAG; 




Fig. 3. Cytokine responses following MCAO/R injury. Serum levels of (A) TNF-α, (B) IL-1β, (C) IL-6, and (D) IL-10 in each rat group were measured from blood 
samples withdrawn 7 days after MCAO/R. Serum cytokine levels  in  the sham  operation (SHG),  saline  (SAG),  low  fat  milk  (LFMG),  and  bovine  colostrum  groups  (BCG). 
Values  are  mean ± SEM ;  n = 8  to  12  (* P < 0.01,  ** P < 0.005,  *** P < 0.001  vs  SHG; 
†P < 0.05, 
††P < 0.01  vs  SAG; 
‡P < 0.05, 
‡‡P < 0.01  vs  LFMG).
after 10 minutes MCAR with no significant differences among 
groups (P > 0.05) (Fig. 1).
Infarct volume
MCAO/R made large infarct in the saline group (40.863 ±
4.907%). LFM (37.073 ± 6.604%) did not reduce the infarct 
volume significantly compared with the saline group (P=0 . 6 2 5 ) . 
BC rats (15.003 ± 3.672%) showed a significant reduction of 
brain infarct volume compared with saline (P< 0.005) and LFM 
rats (P < 0.05) (Fig. 2A and B). 
Serum cytokine (TNF-α, IL-1β, IL-6, and IL-10) measurements
The saline and LFM groups showed significantly elevated 
serum TNF-α levels compared to the sham group (P< 0.005 vs. 
saline; P< 0.001 vs. LFM). The BC group had significantly lower 
serum TNF-α than the saline/LFM groups (P < 0.05 vs. saline; 
P< 0.01 vs. LFM) (Fig. 3A). The saline and LFM groups showed 
significantly elevated serum IL-1β levels compared to the sham 
group (P< 0.001). The BC group had significantly lower IL-1β 
than the saline group (P< 0.001). The BC group had lower IL-1β 
than the LFM group, but the difference was not significant (P
= 0.072) (Fig. 3B). The saline and LFM groups showed 200 Neuroprotective effects of bovine colostrums
(A)
(B)
Fig. 4. Behavioral function tests. Neurological deficit was evaluated in the sham 
operation (SHG), saline (SAG), low fat milk (LFMG), and bovine colostrum 
groups (BCG) just before and 1, 3, and 7 days after MCAO/R using modified 
neurological severity scores (mNSS) graded on a 0 to 18 scale (0, no neurologic 
deficit; 18, maximal deficit) (A) and corner turn test (B). Values are mean±
SEM ;  n = 8  to  12  (* P < 0.01,  ** P < 0.005  vs  SAG; 
†P < 0.05, 
††P < 0.01  vs 
LFMG).
significantly elevated serum IL-6 levels compared to the sham 
group (P< 0.001 vs. Saline; P< 0.005 vs. LFM). The BC group 
had significantly lower IL-6 than the saline/LFM groups (P <
0.01 vs. saline; P < 0.05 vs. LFM) (Fig. 3C). The saline and 
LFM groups showed significantly elevated Serum IL-10 levels 
compared to the sham group (P< 0.01). The BC group had less 
IL-10 than the saline and LFM groups, but the difference was 
not significant (P = 0.105 vs. saline; P= 0.088 vs. LFM) (Fig. 
3D).
Behavioral function assessment 
mNSS: One day after MCAO/R injury, all rats in operation 
groups showed neurologic deficits (saline 10.1 ± 1.02, LFM 10.2
± 1.33, and BC 10.1 ± 1.60), but there were no significant 
differences among the groups till 3 days after the operation. 
Seven days after operation, the BC group (5.4 ± 0.71) scored 
significantly lower than the saline (9.1 ± 0.97) and LFM (8.4 ±
0.99) groups (P< 0.01 vs. saline group, P< 0.05 vs. LFM group) 
(Fig. 4A). 
Corner test: All rats in operation groups showed higher 
percentages of right turns (saline 96.5 ± 1.09, LFM 96.4 ± 1.41, 
and BC 98.1 ± 0.64) at one day after MCAO/R injury, but there 
were no significant differences among the groups. Three days 
after the operation, the BC group (82.0 ± 3.32) made significantly 
fewer right turns compared to the LFM group (92.0 ± 2.61) (P
< 0.05). The BC group (76.1 ± 2.72) made significantly fewer 
right turns than both the saline (88.9 ± 2.54) and LFM (87.6 ±
2.70) groups (P < 0.005 vs. saline group; P < 0.01 vs. LFM 
group) at 7 days (Fig. 4B).
Discussion
Inflammation plays a critical role in ischemic brain injury, and 
anti-inflammatory measures reduce injury and enhance stroke 
recovery. Moreover, reperfusion after focal brain ischemia 
increases the inflammatory reactions [6,23-25]. The major players 
in initiating and modulating the post-ischemic inflammatory 
response are inflammatory cytokines. Proinflammatory cytokines, 
such as tissue necrosis factor-α (TNF-α), interleukin (IL)-1β, and 
IL-6 contribute to pathogenesis, exacerbating ischemic-reperfusion 
brain tissue damage [26,27]. If ischemia activates these cytokines, 
there will be increments of inducible NO synthase, cyclooxygenase- 
2 (COX-2), endothelial adhesion molecules and various chemokine 
productions. This process induces neutrophil adhesion, migration, 
and activation that raise brain tissue inflammation and destruction 
[28]. On the contrary, anti-inflammatory cytokines, such as IL-10, 
can provide neuroprotection and tissue repair in ischemic stroke 
[26]. IL-10 also seems to prevent elevated TNF-α, IL-6, and 
IL-18 levels induced by lipopolysaccharide [29], but the IL-10 
concentration correlates with the SIRS magnitude and elevated 
systemic levels are associated with poor outcome [30].
BC is a source of immune components and nutrients for 
neonatal calves and contains large amounts of protein, immuno-
globulins, growth factors, non-protein nitrogen, fat, ash, vitamins, 
and minerals [31,32]. Protein-energy nutrition after acute stroke 
is a risk factor for poor outcome [33]. An LFM group was 
included in this study to prevent confounding BC and nutrition 
effects due to protein and calorie intake. The results showed that 
the total protein and calorie intake among MCAO/R groups were 
not significantly different. Several cytokines also have been 
found in BC, including both pro-inflammatory cytokines such 
as IL-1β, IL-6, TNF-α, IFN-γ  [34,35] as well as anti- 
inflammatory components, such as IL-1ra, sIL-1RII and sCD14 
[35-37]. This suggests that BC may provide the infant both with 
cytokines to promote activation/inflammation and the means to 
reduce it. 
In vitro, BC is known to modulate cytokine secretion from 
lymphocytes and monocytes [38], and inhibit cyclooxygenase-2 
(COX-2) expression induced by IL-1β  in HT-29 cells [39]. 
Therefore, this in vivo study analyzed three pro-inflammatory 
(TNF-α, IL-1β, and IL-6) and one anti-inflammatory (IL-10) 
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rat MCAO/R model. Serum TNF-α, IL-1β, and IL-6 concentrations 
were increased significantly in MCAO/R groups and decreased 
remarkably after BC administration. Therefore, BC might regulate 
pro-inflammatory cytokine activation during inflammatory 
responses after reperfusion in vivo. The IL-10 serum concentration 
was also increased significantly in the MCAO/R groups and 
decreased marginally after BC administration. These results 
correspond with earlier studies that reported that IL-10 increases 
during early stage after post-ischemia and might inhibit proinfla-
mmatory cytokine release via negative feedback [27,40,41].
MCAO/R may cause cerebral cell death, resulting in local 
infarction. The infarct area represents the degree of brain injury. 
In the present study, rats administered 6 mL/kg BC perorally 
for 7 days after MCAO/R showed a 25.86% and 22.07% reduction 
in infarction volume versus saline and LFM administered rats, 
respectively. These findings show that BC reduces the MCAO- 
induced cerebral infarct, demonstrating that BC protects against 
cerebral ischemia/reperfusion injury. This efficacy may be 
attributed to the many anti-inflammatory substances in BC, such 
as lactoferrin [42].
The brain injury induced by MCAO/R leads to neurobehavioral 
impairment. We performed the modified neurologic severity 
score (mNSS) and corner turn tests to measure neurobehavioral 
changes. The mNSS is sensitive to unilateral cortical injury 
because it reflects multiple asymmetries, including postural, 
sensory, and limb use [43,44]. The corner turn test detects 
sensorimotor and postural asymmetries [22]. The non-ischemic 
rats turned either left or right, but the ischemic rats preferentially 
turned toward the unimpaired, ipsilateral (right) side [45]. In this 
study, all rats in the operation (MCAO/R) groups showed a 
neurologic deficit after MCAO/R injury. The mNSS and corner 
tests showed that MCAO/R-induced impaired neurologic function 
was maximal 24 h after reperfusion and progressively improved 
until 7 days post-MCAO/R. At 7 days the BC group was 
improved remarkably compared to the saline and LFM groups. 
These results were likely in association with the infarct volume, 
which was decreased in BC-feeding rats.
In the present study, we examined the neuroprotective effects 
of BC on a MCAO/R rat model. This is the first report, to our 
knowledge, describing the effects of BC on a rat brain injured 
by transient ischemia. Although this study does not include a 
human model, these results suggest that BC ingestion after brain 
ischemia/reperfusion injury may prevent secondary brain injury 
and promote recovery from the insult. Supplementary studies 
evaluating oxidative stress and/or neurotransmitter release are 
expected to compensate for the limitations found here. This study 
demonstrates that BC consumption inhibits proinflammatory 
cytokine release (TNF-α, IL-1β, and IL-6) and may promote 
anti-inflammatory cytokine release (IL-10) in rat serum 7 days 
after MCAO/R injury. These effects are likely to contribute to 
reducing the infarct lesion volume and degree of neurobehavioral 
change.
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